| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/INTIMM/DXP037 |
| P698 | PubMed publication ID | 19380384 |
| P50 | author | Kei Ikeda | Q55293595 |
| P2093 | author name string | Koichi Hirose | |
| Akira Suto | |||
| Hiroshi Nakajima | |||
| Itsuo Iwamoto | |||
| Shin-ichiro Kagami | |||
| Norihiko Watanabe | |||
| Takayoshi Owada | |||
| Yukari Saito | |||
| Hiroko Kanari | |||
| P2860 | cites work | TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function | Q24314628 |
| Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells | Q24547568 | ||
| Pleiotropic effects of statins | Q24647863 | ||
| Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells | Q27860460 | ||
| Rho GTPases in cell biology | Q27860969 | ||
| Statin therapy and autoimmune disease: from protein prenylation to immunomodulation | Q28236647 | ||
| Transforming growth factor-beta induces development of the T(H)17 lineage | Q28237370 | ||
| The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells | Q28257250 | ||
| TH17 cells in development: an updated view of their molecular identity and genetic programming | Q28276449 | ||
| A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage | Q28287540 | ||
| Protein prenylation: molecular mechanisms and functional consequences | Q29618038 | ||
| Molecular antagonism and plasticity of regulatory and inflammatory T cell programs | Q29619478 | ||
| An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation | Q33876035 | ||
| Signaling and transcription in T helper development | Q33932729 | ||
| Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial | Q34327988 | ||
| Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease | Q34556560 | ||
| Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin | Q36228304 | ||
| Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin | Q36370581 | ||
| IL-4-Stat6 signaling induces tristetraprolin expression and inhibits TNF-alpha production in mast cells. | Q36371553 | ||
| SOCS proteins, cytokine signalling and immune regulation | Q36831668 | ||
| Th17 cell differentiation: the long and winding road | Q37133442 | ||
| Development and characterization of IL-21-producing CD4+ T cells | Q38845667 | ||
| Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo | Q43687301 | ||
| The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease | Q43934617 | ||
| Inhibition of protein geranylgeranylation induces apoptosis in myeloma plasma cells by reducing Mcl-1 protein levels | Q44509632 | ||
| Statins induce suppressor of cytokine signaling-3 in macrophages | Q44673403 | ||
| Oral simvastatin treatment in relapsing-remitting multiple sclerosis | Q44897670 | ||
| Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes. | Q46614190 | ||
| IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells | Q50885474 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 679-689 | |
| P577 | publication date | 2009-04-20 | |
| P1433 | published in | International Immunology | Q15710043 |
| P1476 | title | Protein geranylgeranylation regulates the balance between Th17 cells and Foxp3+ regulatory T cells | |
| P478 | volume | 21 |
| Q58412743 | AT-Rich-Interactive Domain-Containing Protein 5A Functions as a Negative Regulator of Retinoic Acid Receptor-Related Orphan Nuclear Receptor γt-Induced Th17 Cell Differentiation |
| Q43218018 | Atorvastatin attenuates murine anti-glomerular basement membrane glomerulonephritis |
| Q64096419 | Contribution of Statins towards Periodontal Treatment: A Review |
| Q35579498 | Farnesyltransferase inhibitor FTI-277 reduces mortality of septic mice along with improved bacterial clearance |
| Q90389973 | Identifying the anti-inflammatory response to lipid lowering therapy: a position paper from the working group on atherosclerosis and vascular biology of the European Society of Cardiology |
| Q92803859 | Immunometabolic cross-talk in the inflamed heart |
| Q90058507 | Inhibition of stearoyl-CoA desaturases suppresses follicular help T- and germinal center B- cell responses |
| Q37811625 | Innate and adaptive interleukin-17-producing lymphocytes in chronic inflammatory lung disorders |
| Q92569677 | Metabolic regulation of TH17 cells |
| Q97692681 | Metabolic signaling in T cells |
| Q90290841 | Mevalonate promotes differentiation of regulatory T cells |
| Q43139805 | New insight into the immunomodulatory mechanisms of Tretinoin in NMRI mice |
| Q52688337 | Pattern of risks of rheumatoid arthritis among patients using statins: A cohort study with the clinical practice research datalink. |
| Q45772626 | Pitavastatin regulates helper T-cell differentiation and ameliorates autoimmune myocarditis in mice. |
| Q39069187 | Pleiotropic Effects of Statins on the Cardiovascular System |
| Q49861299 | Regulatory T Cell Metabolism in the Hepatic Microenvironment |
| Q43090511 | Simvastatin induces Foxp3+ T regulatory cells by modulation of transforming growth factor-beta signal transduction |
| Q26738584 | Stabilization of high-risk plaques |
| Q35023243 | Statin use and markers of immunity in the Doetinchem cohort study |
| Q33576127 | Statin use in giant cell arteritis: a retrospective study |
| Q38162189 | Statins as modulators of regulatory T-cell biology. |
| Q53123972 | Statins enhance the effects of corticosteroids on the balance between regulatory T cells and Th17 cells. |
| Q28254889 | Sterol metabolism controls T(H)17 differentiation by generating endogenous RORγ agonists |
| Q51201110 | Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis. |
| Q39062582 | Targeting P-selectin glycoprotein ligand-1/P-selectin interactions as a novel therapy for metabolic syndrome |
| Q64248997 | The Pleiotropic Effects of Statins - From Coronary Artery Disease and Stroke to Atrial Fibrillation and Ventricular Tachyarrhythmia |
| Q49630753 | The Role of Lipid Metabolism in T Lymphocyte Differentiation and Survival |
| Q37772197 | The combination of interferon-beta and HMG-CoA reductase inhibition in multiple sclerosis: enthusiasm lost too soon? |
| Q35635336 | The kinase DYRK1A reciprocally regulates the differentiation of Th17 and regulatory T cells |
| Q37137525 | mTOR and lymphocyte metabolism |
Search more.